Skip to main content
. Author manuscript; available in PMC: 2019 Aug 5.
Published in final edited form as: Support Care Cancer. 2018 Jun 12;27(1):147–156. doi: 10.1007/s00520-018-4299-6

Table 2:

Number and proportion of reported unmet needs relating to cancer care experience (n=1947)

Treatment options Side effects Recovery time Life after treatment
Age at survey, in years
 <50 26 (20.0%) 36 (29.0%) 23 (18.6%) 40 (32.3%)
 50–64 128 (21.7%) 168 (28.5%) 148 (25.1%) 203 (34.5%)
 65–74 111 (18.2%) 144 (23.6%) 114 (18.7%) 153 (25.0%)
 ≥75 94 (15.1%) 113 (18.1%) 97 (15.6%) 124 (19.9%)
Gender
 Female 171 (18.0%) 227 (23.8%) 189 (19.9%) 261 (27.4%)
 Male 188 (18.9%) 234 (23.5%) 193 (19.4%) 259 (26.0%)
Race/Ethnicity
 White, non-Hispanic 252 (15.7%) 364 (22.7%) 288 (17.9%) 401 (24.9%)
 Other 105 (32.2%) 95 (29.1%) 89 (27.3%) 112 (34.3%)
Education
 Some high school 52 (30.6%) 58 (34.1%) 41 (24.1%) 51 (30.0%)
 High school graduate 52 (15.1%) 68 (19.7%) 56 (16.2%) 81 (23.5%)
 Some college 123 (18.7%) 151 (23.0%) 136 (20.7%) 190 (28.9%)
 College graduate 61 (20.0%) 84 (27.5%) 62 (20.3%) 78 (25.6%)
 Graduate school 59 (15.4%) 89 (23.2%) 76 (19.8%) 106 (27.6%)
Cancer site
 Colon 242 (17.1%) 295 (20.8%) 258 (18.2%) 338 (23.8%)
 Rectosigmoid 19 (18.8%) 22.8 (23%) 15 (14.9%) 23 (22.8%)
 Rectum 98 (22.9%) 143 (33.4%) 109 (25.5%) 159 (37.2%)
Stage at diagnosis
 0 37 (19.1%) 40 (20.6%) 30 (15.5%) 40 (20.6%)
 1 96 (15.2%) 117 (18.5%) 121 (19.2%) 147 (23.3%)
 2 85 (16.7%) 114 (22.4%) 99 (19.5%) 140 (27.5%)
 3 112 (22.1%) 152 (30.0%) 104 (20.6%) 160 (31.6%)
 4 24 (27.9%) 29 (33.7%) 24 (27.9%) 26 (30.2%)